Nida Zia
Overview
Explore the profile of Nida Zia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zia N, Stroscio M, Dutta M
Materials (Basel)
. 2024 May;
17(10).
PMID: 38793399
The electric potential stimulation of biological structures in aqueous environments is well-known to be a result of the gating of voltage-gated ion channels. Such voltage-gated ion channels are ubiquitous in...
2.
Mushtaq N, Qureshi B, Javed G, Sheikh N, Bakhshi S, Ali Laghari A, et al.
Front Oncol
. 2024 Mar;
14:1325167.
PMID: 38487721
Introduction: Initiated in June 2019, this collaborative effort involved 15 public and private sector hospitals in Pakistan. The primary objective was to enhance the capacity for pediatric neuro-oncology (PNO) care,...
3.
Zia N, Stroscio M, Dutta M
Nanomaterials (Basel)
. 2023 Dec;
13(24).
PMID: 38133042
The feasibility of using quantum dots fabricated from materials with built-in spontaneous polarizations for the electric potential stimulation of biological structures in aqueous environments is evaluated by modeling the electric...
4.
Hamid S, Zia N, Maqsood S, Rafiq N, Fatima M, Syed Y, et al.
Pediatr Blood Cancer
. 2022 Jul;
69(11):e29887.
PMID: 35856658
Introduction: Brain tumors are the most common solid neoplasms and the second most common malignancy in the pediatric age group. Due to the complexity of their management, pediatric central nervous...
5.
Mushtaq N, Mustansir F, Minhas K, Usman S, Qureshi B, Mubarak F, et al.
Pediatr Blood Cancer
. 2022 Apr;
69(9):e29726.
PMID: 35484912
Background: Low- and middle-income countries sustain the majority of pediatric cancer burden, with significantly poorer survival rates compared to high-income countries. Collaboration between institutions in low- and middle-income countries and...
6.
Yaqoob N, Mansoor S, Zia N, Aftab K, Kaleem B, Jamal S
Pak J Med Sci
. 2022 Mar;
38(2):362-368.
PMID: 35310795
Background & Objectives: Retinoblastoma is a malignant intraocular tumor and its treatment requires a multidisciplinary approach. Chemotherapy is an important modality in treatment of retinoblastoma. The purpose of this study...
7.
Yaqoob N, Zia N, Hamid A, Kaleem B, Jamal S, Amin S, et al.
Pediatr Blood Cancer
. 2022 Mar;
69(5):e29625.
PMID: 35253344
Introduction: Retinoblastoma (RB) tumors having high-risk histopathologic features (HRFs) have an increased risk of metastasis and disease relapse. However, RB has not been studied widely in Pakistan. Therefore, we evaluated...
8.
Lucas C, Gupta R, Wu J, Shah K, Ravindranathan A, Barreto J, et al.
Acta Neuropathol
. 2021 Nov;
143(1):109-113.
PMID: 34825267
No abstract available.
9.
Amin S, Rizvi F, Zia N, Ali A, Hamid A, Kumari B
Cureus
. 2021 Jan;
12(11):e11757.
PMID: 33409006
Introduction: A major therapeutic challenge in the salvage of Group D retinoblastoma eyes is the poor response of vitreous seeds to intravenous chemotherapy. The novel use of intravitreal melphalan has...
10.
Moreira D, Rajagopal R, Navarro-Martin Del Campo R, Polanco A, Alcasabas A, Arredondo-Navarro L, et al.
JCO Glob Oncol
. 2020 Apr;
6:583-584.
PMID: 32293939
No abstract available.